DE151036C
(es)
|
|
|
|
|
DE150423C
(es)
|
|
|
|
|
US3093650A
(en)
|
|
1963-06-11 |
|
Alternative synthesis of |
US1889645A
(en)
|
1930-12-22 |
1932-11-29 |
Winthrop Chem Co Inc |
Beta-dimethylaminoethyl ester of para-butylamino-benzoic acid
|
US2441498A
(en)
|
1943-07-15 |
1948-05-11 |
Astra Apotekarnes Kem Fab |
Alkyl glycinanilides
|
US2689248A
(en)
|
1950-06-17 |
1954-09-14 |
Sterling Drug Inc |
Tertiary-aminoalkyl 4-amino-2-alkoxybenzoates and their synth esis
|
GB692332A
(en)
|
1950-07-18 |
1953-06-03 |
Geigy Ag J R |
Improvements relating to quaternary ammonium compounds, and their uses
|
US2774770A
(en)
|
1951-09-20 |
1956-12-18 |
Smith Kline French Lab |
Sulfur-containing amines
|
CH311609A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
CH311610A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
CH311613A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
CH311608A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
CH311611A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
CH311612A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
CH311614A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
CH311607A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
CH311606A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
CH311615A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
US2759975A
(en)
|
1952-05-28 |
1956-08-21 |
Gen Aniline & Film Corp |
Mixed alkyl-benzyl-alkylol quaternary ammonium salts
|
GB751522A
(en)
|
1953-03-16 |
1956-06-27 |
Roche Products Ltd |
Novel derivatives of úÝ-hydroxy-aniline and the manufacture thereof
|
US2783230A
(en)
|
1953-03-16 |
1957-02-26 |
Hoffmann La Roche |
Derivatives of meta hydroxy aniline
|
GB756538A
(en)
|
1953-12-24 |
1956-09-05 |
Bayer Ag |
Alkylation of aromatic amines
|
DE1124496B
(de)
|
1954-02-05 |
1962-03-01 |
Thomae Gmbh Dr K |
Verfahren zur Herstellung von tertiaeren Aminen, ihren Saeureadditionssalzen und quaternaeren Ammoniumverbindungen
|
US2799679A
(en)
|
1955-04-28 |
1957-07-16 |
Bofors Ab |
Process of preparing amides of heterocyclic carboxylic acids
|
DE1018070B
(de)
*
|
1955-09-26 |
1957-10-24 |
Bayer Ag |
Verfahren zur Herstellung von anaesthetisch wirksamen N-Alkylaminocarbonsaeureaniliden
|
US2955111A
(en)
|
1957-01-28 |
1960-10-04 |
Bofors Ab |
Synthesis of n-alkyl-piperidine and n-alkyl-pyrrolidine-alpha-carboxylic acid amides
|
US3160662A
(en)
|
1957-06-26 |
1964-12-08 |
Astra Apotekarnes Kem Fab |
Lower alkylaminoacyl amide anesthetics
|
GB895601A
(en)
|
1957-11-20 |
1962-05-02 |
Sterling Drug Inc |
N[n-(monocarbocyclic aryl) carbamyl-lower-alkyl] amines and their preparation
|
DE1146872B
(de)
|
1959-01-29 |
1963-04-11 |
Bayer Ag |
Verfahren zur Herstellung von organischen Isocyanaten
|
US3049546A
(en)
|
1959-03-05 |
1962-08-14 |
Geigy Chem Corp |
Process for the decarbalkoxylation of alkyl esters of unsaturated, nitrogencontaining carboxylic acids
|
US3264309A
(en)
|
1959-08-24 |
1966-08-02 |
Sterling Drug Inc |
N' [nu-(monocarbocyclic aryl) carbamyllower-alkyl]-1, 5-iminocycloalkanes, -iminocycloalkenes and related compounds
|
US3080327A
(en)
|
1959-11-20 |
1963-03-05 |
T & H Smith Ltd |
Quaternary salts as denaturants for organic substances
|
NL281394A
(es)
|
1961-07-25 |
|
|
|
DE1251764B
(de)
|
1965-08-18 |
1967-10-12 |
C H Boehnnger Sohn Ingelheim/ Rhein |
Verfahren zur Herstellung von antimikrobiell wirksamen 12 3,4-Tetra hydro 9 -ammo acridmiumverbmdungen
|
GB1221061A
(en)
|
1967-01-18 |
1971-02-03 |
May & Baker Ltd |
Quaternary ammonium derivatives, their use as anthelmintics and methods for their preparation
|
US3574216A
(en)
*
|
1968-04-12 |
1971-04-06 |
American Home Prod |
Quaternary 3-pyridinium-2-quinolones
|
US3812147A
(en)
|
1970-12-22 |
1974-05-21 |
Astra Pharma Prod |
Acylxylidide local anaesthetics
|
US3931195A
(en)
|
1971-03-03 |
1976-01-06 |
Mead Johnson & Company |
Substituted piperidines
|
BE786875A
(fr)
|
1971-07-28 |
1973-01-29 |
Astra Pharma Prod |
Amide, methode pour sa preparation et ses compositions therapeutiques
|
US3773939A
(en)
|
1971-11-24 |
1973-11-20 |
Janssen Pharmaceutica Nv |
N-arallyl-n'-aralkyl piperazine pharmaceutical compositions
|
US4069309A
(en)
|
1972-09-19 |
1978-01-17 |
Avon Products, Inc. |
Cationic skin substantive sunscreen composition and method
|
US3900481A
(en)
|
1974-04-01 |
1975-08-19 |
Riker Laboratories Inc |
Derivatives of pyrrolidine and piperidine
|
US4005038A
(en)
|
1974-04-15 |
1977-01-25 |
Peerless Paint And Varnish Corporation |
Paint composition containing denatonium benzoate or lignocaine benzyl octanoate with a latex resin binder for application over old paint films to prevent ingestion of poisons therefrom
|
CS195321B2
(en)
|
1975-12-23 |
1980-01-31 |
Ciba Geigy Ag |
Plant growth suppressing agents
|
BE849723A
(fr)
|
1975-12-23 |
1977-06-22 |
|
Nouveaux regulateurs de la croissance des plantes, a base d'anilides d'acides ammonium quaternaire-alcanoiques
|
US4070347A
(en)
|
1976-08-16 |
1978-01-24 |
Alza Corporation |
Poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality
|
US4147792A
(en)
|
1977-02-04 |
1979-04-03 |
Ciba-Geigy Corporation |
Fungicidal compositions
|
DE2915250A1
(de)
|
1979-04-14 |
1980-10-30 |
Basf Ag |
Salze von alpha -aminoacetaniliden
|
US4293539A
(en)
|
1979-09-12 |
1981-10-06 |
Eli Lilly And Company |
Controlled release formulations and method of treatment
|
US4877805A
(en)
|
1985-07-26 |
1989-10-31 |
Kligman Albert M |
Methods for treatment of sundamaged human skin with retinoids
|
US4757128A
(en)
|
1986-08-01 |
1988-07-12 |
Massachusetts Institute Of Technology |
High molecular weight polyanhydride and preparation thereof
|
US5169637A
(en)
|
1983-03-24 |
1992-12-08 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles
|
ATE40994T1
(de)
|
1983-08-01 |
1989-03-15 |
Astra Laekemedel Ab |
L-n-n-propylpipekolsaeure-2,6-xylidid und dessen herstellung.
|
CA1237671A
(en)
|
1983-08-01 |
1988-06-07 |
Michael W. Fountain |
Enhancement of pharmaceutical activity
|
US5409704A
(en)
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
US4975282A
(en)
|
1985-06-26 |
1990-12-04 |
The Liposome Company, Inc. |
Multilamellar liposomes having improved trapping efficiencies
|
US5023087A
(en)
|
1986-02-10 |
1991-06-11 |
Liposome Technology, Inc. |
Efficient method for preparation of prolonged release liposome-based drug delivery system
|
IE60901B1
(en)
|
1986-08-21 |
1994-08-24 |
Vestar Inc |
Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
|
US5049388A
(en)
|
1986-11-06 |
1991-09-17 |
Research Development Foundation |
Small particle aerosol liposome and liposome-drug combinations for medical use
|
US5032582A
(en)
|
1987-02-27 |
1991-07-16 |
Liposome Technology, Inc. |
Method for treating fungal infections with amphotericin B/cholesterol sulfate composition
|
GB8727504D0
(en)
|
1987-11-24 |
1987-12-23 |
Glaxo Group Ltd |
Chemical compositions
|
US4994213A
(en)
|
1988-05-17 |
1991-02-19 |
Liposome Technology, Inc. |
Method of preparing lipid structures
|
US5082866A
(en)
|
1988-06-01 |
1992-01-21 |
Odontex, Inc. |
Biodegradable absorption enhancers
|
US4980378A
(en)
|
1988-06-01 |
1990-12-25 |
Odontex, Inc. |
Biodegradable absorption enhancers
|
US5194581A
(en)
|
1989-03-09 |
1993-03-16 |
Leong Kam W |
Biodegradable poly(phosphoesters)
|
US5194266A
(en)
|
1989-08-08 |
1993-03-16 |
Liposome Technology, Inc. |
Amphotericin B/cholesterol sulfate composition and method
|
US5356633A
(en)
|
1989-10-20 |
1994-10-18 |
Liposome Technology, Inc. |
Method of treatment of inflamed tissues
|
DD298726A5
(de)
|
1989-12-29 |
1992-03-12 |
Biologische Zentralanstalt Berlin,De |
Fungizide mittel
|
DD298723A5
(de)
|
1989-12-29 |
1992-03-12 |
Biologische Zentralanstalt Berlin,De |
Biozide mittel
|
DD298727A5
(de)
|
1989-12-29 |
1992-03-12 |
Biologische Zentralanstalt Berlin,De |
Mikrobizide mittel
|
DE69211691T2
(de)
|
1991-04-19 |
1997-01-16 |
Nexstar Pharmaceuticals Inc |
Pharmazeutische formulierung und pharmazeutisches verfahren
|
US5176907A
(en)
|
1991-08-13 |
1993-01-05 |
The Johns Hopkins University School Of Medicine |
Biocompatible and biodegradable poly (phosphoester-urethanes)
|
FR2688219B1
(fr)
|
1992-03-03 |
1994-07-08 |
Sanofi Elf |
Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
|
GR1002207B
(en)
|
1992-08-06 |
1996-03-27 |
Johnson & Johnson Consumer |
Skin care compositions containing imidazoles.
|
US5552155A
(en)
|
1992-12-04 |
1996-09-03 |
The Liposome Company, Inc. |
Fusogenic lipsomes and methods for making and using same
|
US5480971A
(en)
|
1993-06-17 |
1996-01-02 |
Houghten Pharmaceuticals, Inc. |
Peralkylated oligopeptide mixtures
|
US5409805A
(en)
|
1993-07-29 |
1995-04-25 |
Konica Corporation |
Solid processing agent for silver halide photographic light-sensitive materials
|
US6051576A
(en)
|
1994-01-28 |
2000-04-18 |
University Of Kentucky Research Foundation |
Means to achieve sustained release of synergistic drugs by conjugation
|
US5591317A
(en)
|
1994-02-16 |
1997-01-07 |
Pitts, Jr.; M. Michael |
Electrostatic device for water treatment
|
US5716622A
(en)
|
1995-01-06 |
1998-02-10 |
The Rockefeller University |
Functionally active regions of signal transducer and activators of transcription
|
US5783683A
(en)
|
1995-01-10 |
1998-07-21 |
Genta Inc. |
Antisense oligonucleotides which reduce expression of the FGFRI gene
|
WO1996040061A1
(en)
|
1995-06-07 |
1996-12-19 |
Nexstar Pharmaceuticals, Inc. |
Method for encapsulating pharmaceutical materials
|
US5747470A
(en)
|
1995-06-07 |
1998-05-05 |
Gen-Probe Incorporated |
Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA
|
WO1997004770A1
(en)
|
1995-07-31 |
1997-02-13 |
Merck & Co., Inc. |
2-(fluorenonyl)-carbapenems, compositions and methods of use
|
US6413961B1
(en)
|
1995-12-12 |
2002-07-02 |
Omeros Medical Systems, Inc. |
Irrigation solution and method for inhibition of pain and inflammation
|
SE508357C2
(sv)
|
1996-01-02 |
1998-09-28 |
Kay Laserow |
Mätinstrument för mätning av smärta jämte ett förfarande för att med ett mätinstrument mäta smärta
|
WO1998024428A1
(en)
|
1996-12-02 |
1998-06-11 |
Brigham & Women's Hospital, Inc. |
Long-acting local anesthetics
|
SE9604751D0
(sv)
|
1996-12-20 |
1996-12-20 |
Astra Ab |
New therapy
|
US5837713A
(en)
|
1997-02-26 |
1998-11-17 |
Mayo Foundation For Medical Education And Research |
Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids
|
US6008318A
(en)
|
1997-06-18 |
1999-12-28 |
Guilford Pharmaceuticals Inc. |
Two-stage solution polymerization of high molecular weight poly(phosphoesters)
|
RU2105554C1
(ru)
|
1997-06-24 |
1998-02-27 |
Всероссийский научный центр по безопасности биологически активных веществ |
N-(2,4,6-триметилфенилкарбамоилметил)-n-аллилморфолиний бромид, проявляющий противоишемическое и антиаритмическое действие при ишемической болезни сердца и способ его получения
|
US6028163A
(en)
|
1997-06-27 |
2000-02-22 |
Guilford Pharmaceuticals Inc. |
Solution polymerization of high molecular weight poly(phosphoesters) in toluene
|
DE69833858T2
(de)
|
1997-07-08 |
2007-02-22 |
Ono Pharmaceutical Co. Ltd. |
Aminosäurederivate
|
US6623040B1
(en)
|
1997-09-03 |
2003-09-23 |
Recot, Inc. |
Method for determining forced choice consumer preferences by hedonic testing
|
TW536401B
(en)
|
1997-09-03 |
2003-06-11 |
Cardiome Pharma Corp |
A pharmaceutical composition of N,N-bis(phenylcarbamoylmethyl)dimethylammomum chloride and derivatives for the treatment of pain
|
US5891919A
(en)
|
1997-09-19 |
1999-04-06 |
Burlington Bio-Medical & Scientific Corp. |
Denatonium capsaicinate and methods of producing the same
|
US6083996A
(en)
|
1997-11-05 |
2000-07-04 |
Nexmed Holdings, Inc. |
Topical compositions for NSAI drug delivery
|
US6140351A
(en)
|
1997-12-19 |
2000-10-31 |
Berlex Laboratories, Inc. |
Ortho-anthranilamide derivatives as anti-coagulants
|
US6207290B1
(en)
|
1998-04-07 |
2001-03-27 |
Burlington Bio-Medical & Scientific Corp. |
Antifoulant compositions and methods of treating wood
|
BR9911094A
(pt)
|
1998-06-09 |
2001-10-30 |
Nortran Pharmaceuticals Inc |
Composições e métodos para o tratamento detosse
|
JP2000143635A
(ja)
|
1998-06-10 |
2000-05-26 |
Takeda Chem Ind Ltd |
血管新生阻害剤
|
US6153212A
(en)
|
1998-10-02 |
2000-11-28 |
Guilford Pharmaceuticals Inc. |
Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same
|
FR2787706B1
(fr)
|
1998-12-23 |
2002-06-14 |
Oreal |
Procede de teinture mettant en oeuvre une amine cationique heterocyclique et un compose choisi parmi un aldehyde, une cetone, une quinone et un derive de la di-imino-isoindoline ou de la 3-amino-isoindolone
|
US7507545B2
(en)
|
1999-03-31 |
2009-03-24 |
Cardiome Pharma Corp. |
Ion channel modulating activity method
|
US6103255A
(en)
|
1999-04-16 |
2000-08-15 |
Rutgers, The State University |
Porous polymer scaffolds for tissue engineering
|
US6118020A
(en)
|
1999-05-19 |
2000-09-12 |
Nexmed Holdings, Inc. |
Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
|
FR2794644B1
(fr)
|
1999-06-09 |
2004-04-16 |
Oreal |
Utilisation de sels d'arenediazonium et de copulants cationiques pour la teinture reactive de fibres keratiniques
|
ES2215712T3
(es)
|
1999-09-09 |
2004-10-16 |
Kumiai Chemical Industry Co., Ltd. |
Derivados de pirimidina y herbicidas que los contienen.
|
US6355637B1
(en)
|
1999-10-01 |
2002-03-12 |
Advanced Medicine, Inc. |
Local anesthetic compounds
|
US6608094B2
(en)
|
1999-10-06 |
2003-08-19 |
Torrent Pharmaceuticals Ltd. |
Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
|
US20020103228A1
(en)
|
1999-10-06 |
2002-08-01 |
Torrent Pharmaceuticals Ltd. |
Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
|
PL356032A1
(en)
|
1999-12-15 |
2004-06-14 |
Usb Farchim S.A |
Cyclic quaternary ammonium compounds
|
HUP0204014A3
(en)
|
1999-12-15 |
2005-04-28 |
Ucb Farchim Sa |
Quaternary salts of-n-substituted cyclic or acyclic amines and their use as pharmaceutical compositions
|
AU3162001A
(en)
|
1999-12-21 |
2001-07-03 |
Id-Pharma Gmbh |
Medicament, a method for its production and the use thereof
|
US20050009016A1
(en)
|
2000-05-04 |
2005-01-13 |
Moskowitz David W. |
Tgfbeta-rII promoter polymorphisms
|
EP1296683A2
(en)
|
2000-06-23 |
2003-04-02 |
Mayo Foundation For Medical Education And Research |
Methods of treating neutrophil-related diseases with topical anesthetics
|
US20030176426A1
(en)
|
2000-07-13 |
2003-09-18 |
Alteon, Inc. |
Method for treating fibrotic diseases or other indications with imidazolium agents
|
DE10039449A1
(de)
|
2000-08-11 |
2003-07-24 |
Id Pharma Gmbh I Ins |
Verwendung einer lokalanästhetikumhaltigen Zusammensetzung zur Behandlung von Hyperalgesien
|
AU2002214626A1
(en)
*
|
2000-09-29 |
2002-04-08 |
Cor Therapeutics, Inc. |
Quaternary amines and related inhibitors of factor xa
|
US6766319B1
(en)
|
2000-10-31 |
2004-07-20 |
Robert J. Might |
Method and apparatus for gathering and evaluating information
|
US6884782B2
(en)
|
2000-11-08 |
2005-04-26 |
Amgen Inc. |
STAT modulators
|
JP2004521111A
(ja)
|
2001-01-25 |
2004-07-15 |
ユーロ−セルティーク,エス.エイ. |
局所麻酔薬および使用法
|
US20040146590A1
(en)
|
2001-03-22 |
2004-07-29 |
Iadarola Michael J |
Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
|
WO2002089849A1
(en)
|
2001-05-07 |
2002-11-14 |
Corium International |
Compositions and delivery systems for administration of a local anesthetic agent
|
ATE432929T1
(de)
|
2001-06-15 |
2009-06-15 |
Vertex Pharma |
5-(2-aminopyrimidin-4-yl)benzisoxazole als proteinkinasehemmer
|
US7157103B2
(en)
|
2001-08-06 |
2007-01-02 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing irritant
|
US20030068276A1
(en)
|
2001-09-17 |
2003-04-10 |
Lyn Hughes |
Dosage forms
|
ITMI20012025A1
(it)
|
2001-09-28 |
2003-03-28 |
Dompe Spa |
Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono
|
DE60309888T2
(de)
|
2002-08-02 |
2007-06-21 |
Université Libre de Bruxelles |
Apolipoprotein l-i zur behandlung von trypanosomen-erkrankungen
|
CA2504044A1
(en)
|
2002-11-01 |
2004-05-21 |
Merck & Co., Inc. |
Carbonylamino-benzimidazole derivatives as androgen receptor modulators
|
WO2004091521A2
(en)
|
2003-04-10 |
2004-10-28 |
Neurogesx, Inc. |
Methods and compositions for administration of trpv1 agonists
|
WO2004093814A2
(en)
|
2003-04-22 |
2004-11-04 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a sodium channel blocker
|
ES2223277B1
(es)
|
2003-06-19 |
2006-03-01 |
Fernando Bouffard Fita |
Composicion anestesica para administracion topica.
|
JP2005017606A
(ja)
|
2003-06-25 |
2005-01-20 |
Fuji Photo Film Co Ltd |
熱現像感光材料
|
WO2005014849A2
(en)
|
2003-07-03 |
2005-02-17 |
Euro-Celtique, S.A. |
Genes associated with responses to neuropathic pain
|
US8361467B2
(en)
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
NO20034069L
(no)
|
2003-09-12 |
2005-03-14 |
Aximed As |
Fremstilling og bruk av capsaicinderivater
|
US20070149469A1
(en)
|
2003-10-02 |
2007-06-28 |
Christian Korherr |
Medical use of tbk-1 or of inhibitors thereof
|
US20050142596A1
(en)
|
2003-11-14 |
2005-06-30 |
Krolewski Andrzej S. |
Methods of diagnosing renal and cardiovascular disease
|
AU2004298511B2
(en)
|
2003-12-11 |
2011-08-11 |
Board Of Regents, The University Of Texas System |
Compounds for treatment of cell proliferative diseases
|
WO2005063777A1
(en)
|
2003-12-23 |
2005-07-14 |
Corus Pharma |
Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
|
WO2005089206A2
(en)
|
2004-03-13 |
2005-09-29 |
Irm Llc |
Modulators of ion channel trpa1
|
US7161034B2
(en)
|
2004-04-20 |
2007-01-09 |
Dade Behring Inc. |
Lidocaine analogs and methods of making and using same
|
US20060106020A1
(en)
|
2004-04-28 |
2006-05-18 |
Rodgers James D |
Tetracyclic inhibitors of Janus kinases
|
CA2569155A1
(en)
|
2004-06-02 |
2005-12-15 |
Sri International |
Formulations comprising a capsaicinoid a local anesthetic and/or an antipruritic agent for the treatment of pain
|
RU2258700C1
(ru)
|
2004-06-28 |
2005-08-20 |
Государственное образовательное учреждение высшего профессионального образования "Мордовский государственный университет им. Н.П. Огарева" |
Четвертичное аммониевое производное лидокаина, обладающее противоаритмической активностью и способ его получения
|
CA2573122A1
(en)
|
2004-07-24 |
2006-02-02 |
Laboratorios Del Dr. Esteve, S.A. |
Use of compounds active on the sigma receptor for the treatment of mechanical allodynia
|
ITMI20041566A1
(it)
|
2004-07-30 |
2004-10-30 |
Indena Spa |
"trpv1 agonisti, formulazioni che li contengono e loro usi"
|
JP2008513444A
(ja)
|
2004-09-20 |
2008-05-01 |
コラス ファーマ インコーポレイテッド |
リドカイン及び他の局所麻酔剤の標的運搬並びに咳そう及び咳の発作の処置のための方法
|
US7947682B2
(en)
|
2004-12-29 |
2011-05-24 |
University Of Southern California |
Substituted N′-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazides as anti-cancer agents
|
US20090306429A1
(en)
|
2004-12-06 |
2009-12-10 |
Henk Pluim |
Preparation of a quaternary ammonium hydroxide and use thereof for the preparation of a quaternary ammonium salt
|
JP2008514648A
(ja)
|
2004-12-16 |
2008-05-08 |
アドバンスト インハレーション リサーチ,インコーポレイテッド |
肺疾患のための組成物および方法
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
WO2006133588A1
(en)
|
2005-06-13 |
2006-12-21 |
Oncalis Ag |
ARYL UREA COMPOUNDS AS β-SECRETASE INHIBITORS
|
GB0517966D0
(en)
*
|
2005-09-02 |
2005-10-12 |
Novartis Ag |
Organic compounds
|
WO2007038215A1
(en)
|
2005-09-22 |
2007-04-05 |
Incyte Corporation |
Tetracyclic inhibitors of janus kinases
|
ES2542989T3
(es)
|
2005-10-12 |
2015-08-13 |
Idera Pharmaceuticals, Inc. |
Compuestos oligonucleótidos inmuno reguladores (IRO) para modular la respuesta inmune basada en receptor semejante a Toll
|
EP2348023B9
(en)
|
2005-12-13 |
2017-03-08 |
Incyte Holdings Corporation |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
|
JP2009520700A
(ja)
|
2005-12-21 |
2009-05-28 |
ペインセプター ファーマ コーポレーション |
依存性イオンチャネルを調節するための組成物および方法
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
EP1867338A1
(en)
|
2006-05-30 |
2007-12-19 |
Université Libre De Bruxelles |
Pharmaceutical composition comprising apolipoproteins for the treatment of human diseases
|
EP2101819B1
(en)
|
2006-11-20 |
2013-01-09 |
President and Fellows of Harvard College |
Methods, compositions, and kits for treating pain and pruritis
|
JP5492565B2
(ja)
|
2006-12-22 |
2014-05-14 |
インサイト・コーポレイション |
Janusキナーゼ阻害剤としての置換複素環
|
GB0702382D0
(en)
|
2007-02-07 |
2007-03-21 |
Argenta Discovery Ltd |
New salt
|
CL2008000835A1
(es)
|
2007-03-23 |
2008-10-03 |
Icagen Inc Pfizer Ltd |
Compuestos derivados de sulfonamidas, inhibidores de los canales de calcio; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor, sindrome de intestino irritable, enfermedad de crohn, taquiarritm
|
ES2609912T3
(es)
|
2007-06-22 |
2017-04-25 |
Hydra Biosciences, Inc. |
Compuestos de 2,6-dioxo, -2,3-dihidro-1h-purina útiles para el tratamiento de trastornos relacionados con la actividad del canal trpa1
|
WO2009026107A1
(en)
|
2007-08-17 |
2009-02-26 |
Portola Pharmaceuticals, Inc. |
Protein kinase inhibitors
|
CN101156851A
(zh)
|
2007-09-27 |
2008-04-09 |
刘全胜 |
盐酸尼卡地平分散片及其制备方法
|
EP2090311A1
(en)
|
2008-02-18 |
2009-08-19 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy
|
JP2011513484A
(ja)
|
2008-03-11 |
2011-04-28 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
疼痛および掻痒症を治療するための方法、組成物、およびキット
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
EP2271631B1
(en)
|
2008-04-22 |
2018-07-04 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
US20120108614A1
(en)
|
2008-05-14 |
2012-05-03 |
Chong Jayhong A |
Compounds and compositions for treating chemical warfare agent-induced injuries
|
EA020766B1
(ru)
|
2008-07-08 |
2015-01-30 |
Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем |
Ингибиторы пролиферации и активации переносчика сигнала и активатора транскрипции (stats)
|
DE102008037682A1
(de)
|
2008-08-14 |
2010-04-08 |
Strackharn, Klaus, Dr.med. |
Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
|
CN101347427A
(zh)
|
2008-09-22 |
2009-01-21 |
北京理工大学 |
一种沙坦化合物或其可药用盐和钙通道阻断剂或可药用盐的复方
|
CL2009001884A1
(es)
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
AU2009302468A1
(en)
|
2008-10-06 |
2010-04-15 |
Idera Pharmaceuticals, Inc. |
Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
|
WO2010111471A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
EP2995303A1
(en)
|
2009-07-10 |
2016-03-16 |
President and Fellows of Harvard College |
Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
|
US9023355B2
(en)
|
2010-04-13 |
2015-05-05 |
Beth Israel Deaconess Medical Center, Inc. |
Compositions and methods for treating renal disease
|
WO2011133474A2
(en)
|
2010-04-18 |
2011-10-27 |
Beth Israel Deaconess Medical Center |
Methods of predicting predisposition to or risk of kidney disease
|
WO2012030912A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
7-cyclylquinazoline derivatives and methods of use thereof
|
US20120148520A1
(en)
|
2010-12-10 |
2012-06-14 |
Michael Strobel |
Organic Iodine Complex Durable Barrier With Antimicrobial Preparations
|
US8916565B2
(en)
|
2011-02-02 |
2014-12-23 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
|
WO2012166617A2
(en)
|
2011-05-27 |
2012-12-06 |
Cytocure Llc |
Methods, compositions, and kits for the treatment of cancer
|
AU2012321111A1
(en)
|
2011-10-31 |
2013-05-16 |
Purdue Pharma L.P. |
Quaternized amines as sodium channel blockers
|
WO2013130808A1
(en)
|
2012-02-29 |
2013-09-06 |
D.E. Shaw Research, Llc |
Methods for screening voltage gated proteins
|
US9517223B2
(en)
|
2012-08-07 |
2016-12-13 |
The General Hospital Corporation |
Methods to treat neurodegenerative diseases
|
WO2014044849A1
(en)
*
|
2012-09-24 |
2014-03-27 |
Boehringer Ingelheim International Gmbh |
Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
|
US8822537B2
(en)
|
2012-09-27 |
2014-09-02 |
Achelios Therapeutics, Inc. |
Topical ketoprofen composition
|
LV15002B
(lv)
*
|
2013-10-29 |
2015-07-20 |
Latvijas Organiskās Sintēzes Institūts |
Heterociklā aizvietoti [(2-karboksi vai -metoksikarbonil)fenilkarbamoil-metil (vai trimetilēn)] piridīnija vai izohinolīnija bromīdi kā hidroksikarbonskābju receptoru saimes (HCA2) jauna ligandu klase
|
CN105566148B
(zh)
|
2014-10-14 |
2017-10-03 |
沈阳中化农药化工研发有限公司 |
一种季铵盐类化合物及其应用
|
WO2016140942A1
(en)
|
2015-03-04 |
2016-09-09 |
The Procter & Gamble Company |
Fibrous elements, fibrous structures, and products comprising a deterrent agent and methods for making same
|
CN106310289B
(zh)
|
2015-06-24 |
2020-10-13 |
天津键凯科技有限公司 |
一种聚乙二醇和麻醉药的结合物及其制备方法
|
US11021443B2
(en)
*
|
2015-08-03 |
2021-06-01 |
President And Fellows Of Harvard College |
Charged ion channel blockers and methods for use
|
DE102016009766A1
(de)
|
2016-08-11 |
2018-02-15 |
Julius-Maximilians-Universität Würzburg |
Herstellung von Bitterstoffderivaten
|
JOP20190245A1
(ar)
|
2017-04-20 |
2019-10-15 |
Novartis Ag |
أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط
|
CN108929263B
(zh)
|
2017-05-26 |
2022-07-22 |
中国医学科学院药物研究所 |
芳酰胺类Kv2.1抑制剂及其制备方法、药物组合物和用途
|
US10835505B2
(en)
|
2018-06-11 |
2020-11-17 |
Aardvark Therapeutics, Inc. |
Oral pharmaceutical formulation for weight loss, diabetes and related disorders
|
US10786485B1
(en)
|
2019-03-11 |
2020-09-29 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
US10780083B1
(en)
|
2019-03-11 |
2020-09-22 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
JP2022527690A
(ja)
|
2019-03-11 |
2022-06-03 |
ノシオン セラピューティクス,インコーポレイテッド |
荷電したイオンチャンネル遮断薬および使用方法
|
BR112021017809A2
(pt)
|
2019-03-11 |
2021-11-23 |
Nocion Therapeutics Inc |
Bloqueadores de canais iônicos substituídos por éster e métodos para uso
|
WO2020185881A1
(en)
|
2019-03-11 |
2020-09-17 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
WO2021091585A1
(en)
|
2019-11-06 |
2021-05-14 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
WO2021091586A1
(en)
|
2019-11-06 |
2021-05-14 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|